TCMBANKIN008788 |
Aspidin |
AIDS-048751; AIDS048751; aspidin; 2,5-Cyclohexadien-1-one, 2-((2,6-dihydroxy-4-methoxy-3-methyl-5-(1-oxobutyl)phenyl)methyl)-3,5-dihydroxy-4,4-dimethyl-6-(1-oxobutyl)-; 4-[[2,6-dihydroxy-4-methoxy-3-methyl-5-(1-oxobutyl)phenyl]methyl]-3,5-dihydroxy-6,6-dimethyl-2-(1-oxobutyl)-1-cyclohexa-2,4-dienone; 2-butanoyl-4-[(3-butanoyl-2,6-dihydroxy-4-methoxy-5-methyl-phenyl)methyl]-3,5-dihydroxy-6,6-dimethyl-cyclohexa-2,4-dien-1-one; 4-08-00-03749 (Beilstein Handbook Reference); BRN 2068604; 2-butyryl-4-(3-butyryl-2,6-dihydroxy-4-methoxy-5-methyl-benzyl)-3,5-dihydroxy-6,6-dimethyl-cyclohexa-2,4-dien-1-one; Aspidin VV; 584-28-1; C10672; 2-butanoyl-4-[(3-butanoyl-2,6-dihydroxy-4-methoxy-5-methylphenyl)methyl]-3,5-dihydroxy-6,6-dimethylcyclohexa-2,4-dien-1-one; Aspidin BB; 2-Butyryl-6-(3-butyryl-2,6-dihydroxy-4-methoxy-5-methylbenzyl)-3,5-dihydroxy-4,4-dimethylcyclohexa-2,5-dien-1-one |
C25H32O8 |
460.52 |
CCCC(=O)C1=C(C(=C(C(C1=O)(C)C)O)CC2=C(C(=C(C(=C2O)C)OC)C(=O)CCC)O)O |
TCMBANKIN013304 |
Aspidinol |
2',6'-Dihydroxy-4'-methoxy-3'-methylbutyrophenone; 519-40-4; 1-(2,6-dihydroxy-4-methoxy-3-methyl-phenyl)butan-1-one; Butyrophenone, 2',6'-dihydroxy-4'-methoxy-3'-methyl-; aspidinol; Aspidinol B; C10673; 1-(2,6-Dihydroxy-4-methoxy-3-methylphenyl)-1-butanone; 1-(2,6-dihydroxy-4-methoxy-3-methylphenyl)butan-1-one |
C12H16O4 |
224.25 |
CCCC(=O)C1=C(C(=C(C=C1O)OC)C)O |
TCMBANKIN016362 |
norflavaspidic acid |
norflavaspidicacid |
C43H48O16 |
|
CCC(=O)C1=C(C(=C(C(=C1O)CC2=C(C(C(=O)C(=C2O)C(=O)CC)(C)C)O)O)CC3=C(C(=C(C(=C3O)C(=O)CC)O)CC4=C(C(C(=O)C(=C4O)C(=O)CC)(C)C)O)O)O |
TCMBANKIN032788 |
trisflavaspidicacid |
|
C35H42O12 |
654.7 g/mol |
CCCC(=O)C1=C(C(=C(C(=C1O)CC2=C(C(=C(C(=C2O)C(=O)CCC)O)CC3=C(C(C(=O)C(=C3O)C(=O)CCC)(C)C)O)O)O)C)O |
TCMBANKIN041268 |
trisaspidin |
|
C36H44O12 |
668.7 g/mol |
CCCC(=O)C1=C(C(=C(C(=C1O)CC2=C(C(C(=O)C(=C2O)C(=O)CCC)(C)C)O)O)CC3=C(C(=C(C(=C3O)C)OC)C(=O)CCC)O)O |
TCMBANKIN043863 |
Trisdesaspidin BBB |
|
|
|
|
TCMBANKIN058401 |
Norharman |
244-63-3; BSPBio_002322; ZINC00066039; SMR000058207; KBio3_001542; BRN 0128414; Carbazoline; KBio2_001612; InChI=1/C11H8N2/c1-2-4-10-8(3-1)9-5-6-12-7-11(9)13-10/h1-7,13; 9H-beta-carboline; AIDS109050; 5-23-08-00220 (Beilstein Handbook Reference); norharman; Norharmane; EINECS 205-959-0; 9H-Pyrido[3,4-B]indole; Prestwick_363; NSC84417; AG-670/31510009; KBio2_006748; .beta.-Carboline; MLS000069651; Spectrum4_001915; Spectrum2_000588; AIDS-109050; Spectrum_001132; 9H-$b-carboline; SMP2_000349; NCIOpen2_001217; KBioSS_001612; 2,9-Diazafluorene; Spectrum5_000630; KBio2_004180; SDCCGMLS-0003278.P003; Carbazoline (VAN); 2-Azacarbazole; CCRIS 6915; ST5307983; Spectrum3_000741; SPBio_000436; NSC 84417; NCGC00021302-03; N6252_SIGMA; KBioGR_002537; WLN: T B656 EN HMJ;beta-carboline |
C11H8N2 |
168.19 |
C1=CC=C2C(=C1)C3=C(N2)C=NC=C3 |
TCMBANKIN060764 |
albaspidin |
|
C25H32O8 |
460.5 g/mol |
CCCC(=O)C1=C(C(=C(C(C1=O)(C)C)O)CC2=C(C(C(=O)C(=C2O)C(=O)CCC)(C)C)O)O |